The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while keeping EU industry competitive.

The trial showcases UK science and innovation and is the last step in a series of clinical trials to see if the capsule sponge test could be offered in the cancer screening programmes of the four UK ...

We will interview a subsample of 20 participants to explore their experiences of the trial interventions. Discussion The PROSPER study is the first multicentre UK clinical trial to investigate the ...

National Institute of Neurological Disorders and Stroke (NINDS) trial of tissue plasminogen activator for acute ischaemic ...

The online BREAKING-ICE App, where ICE stands for informative censoring exploration, is designed to visually demonstrate the impact of informative censoring on trial outcomes. The app aims to ...

Representatives of industry and regulation will meet in June to discuss paths forward for the UK’s clinical trials sector ...

In brief, we undertook a cohort study analysing routinely collected data gathered from the UK’s Clinical Practice Research Datalink (CPRD) (ISAC approval number 17_024R).8 This database of ...

I've been reflecting on the incredible work underway here to make it faster and easier to run clinical trials in the UK - for the benefit of patients, the NHS, and the wider research community.

New regulations - which represent the most significant update to the UK clinical trials landscape in 20 years - are designed to put participants firmly at the centre of how trials are run, while ...

The Medicines and Healthcare products Regulatory Agency has announced significant progress in modernising the UK’s clinical trials framework, marking the most substantial update in two decades. The ...

The progress the UK has made as a global contributor to clinical trials is “remarkable”, says Lord James O’Shaughnessy, former health minister and author of the landmark report into the ...